Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Bicycle Therapeutics PLC changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 105 | 82 | −23 |
| Shares | 20.2M | 22.7M | +2.52M (+12.5%) |
| Value | $884.5M | $381.1M | −$503.4M (−56.9%) |
New holders (17)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 1,048,516 | $17.6M | 3.51% |
| Candriam Luxembourg S.C.A. | 834,676 | $14.0M | 0.12% |
| Citadel Advisors LLC | 243,334 | $4.08M | 0.01% |
| Pura Vida Investments, LLC | 183,121 | $3.07M | 0.49% |
| ExodusPoint Capital Management, LP | 182,125 | $3.06M | 0.04% |
| Alliancebernstein L.P. | 132,306 | $2.22M | 0.00% |
| Voloridge Investment Management, LLC | 123,050 | $2.06M | 0.01% |
| Allianz Asset Management GmbH | 84,485 | $1.42M | 0.00% |
| UBS Oconnor LLC | 57,625 | $967.0K | 0.01% |
| Eagle Health Investments LP | 23,500 | $394.0K | 0.09% |
| Alps Advisors Inc | 17,590 | $295.0K | 0.00% |
| Man Group plc | – | $233.0K | 0.00% |
| Trexquant Investment LP | 10,899 | $183.0K | 0.01% |
| Quantbot Technologies LP | 3,612 | $60.0K | 0.01% |
| BNP Paribas Arbitrage, SA | 333 | $5.59K | 0.00% |
| Crewe Advisors LLC | 83 | $1.00K | 0.00% |
| Wells Fargo & Company | 1 | $0 | 0.00% |
Sold out (40)
Institutions that held Bicycle Therapeutics PLC at the end of Q1 2022 and filed for Q2 2022 without it.